Overall rank by patents
#3,076
Across all tracked assignees
USPTO PatentsView assignee record - 123 granted patents across 59 technology areas, active 2015–2022. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G01F (MEASURING VOLUME, VOLUME FLOW, MASS FLOW OR LIQUID LEVEL; METERING BY VOLUME).
The verdict
Endress+hauser holds 123 US patents across 59 technology areas, rank #3,076 of 50,000 tracked assignees.
Endress+hauser Gmbh+co.kg has been granted 123 US utility patents between 2015 and 2022, placing Endress+hauser Gmbh+co.kg at rank #3,076 across all assignees tracked by PlainPatent. This portfolio spans 59 distinct Cooperative Patent Classification (CPC) subclasses, averaging 11.2 claims per patent with primary concentration in G01F (MEASURING VOLUME, VOLUME FLOW, MASS FLOW OR LIQUID LEVEL; METERING BY VOLUME). As a Foreign Corporation, Endress+hauser Gmbh+co.kg is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Endress+hauser sits between Mölnlycke Health Care AB (124 patents, rank #3,072) and Festo SE & Co. KG (123 patents, rank #3,080) - the closest US assignees by grant volume. The composite Innovation Score of 50.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 3 grants, compared with 120 in the 2015–2019 window, a -97% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Endress+hauser Gmbh+co.kg's 11.2 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while a multi-domain presence across 59 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Endress+hauser Gmbh+co.kg against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Mölnlycke Health Care AB
124 patents
Oceaneering International, Inc.
124 patents
Trudell Medical International Inc.
124 patents
Abbott Medical Optics Inc.
123 patents
EndoChoice, Inc.
123 patents
Everi Games Inc.
123 patents
FUTABA INDUSTRIAL CO., LTD.
123 patents
Festo SE & Co. KG
123 patents
ENDRESS+HAUSER GMBH+CO.KG
123 patents
What this shows Endress+hauser holds 123 patents at rank #3,076, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #3,076 in granted patent volume.
Other assignees with the most granted patents in Endress+hauser's primary technology class.
Endress+hauser's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
51 Top 13% higher than 87% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 26 | 21.1% |
| 2016 | 26 | 21.1% |
| 2017 | 35 | 28.5% |
| 2018 | 32 | 26.0% |
| 2019 | 1 | 0.8% |
| 2020 | 1 | 0.8% |
| 2021 | 1 | 0.8% |
| 2022 | 1 | 0.8% |
Top 15 of 59 technology areas
Overall rank by patents
#3,076
Across all tracked assignees
50.6 out of 100
How to use this portfolio
Endress+hauser's 123 grants land it in the top 13% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.